Colorectal cancer (CRC) is the third most common cancer and
the third leading cause of cancer death in the United States (1).
For the past two decades, the incidence and mortality rate of
CRC has been reduced due to the early detection and removal
of precancerous polyps/adenomas by screening colonoscopy
(2-4). However, the risk stratification of the target screening
population needs to be further addressed in order to improve